CWM Advisors »

Protagonist Therapeutics shares owned by CWM Advisors

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by CWM Advisors from 13F filings

Historical chart of CWM Advisors investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by CWM Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by CWM Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $385k 17k 22.93
2023-09-30 $310k 19k 16.68

More positions owned by CWM Advisors

Northern Lts Fd Tr Iv Inspire Corp Bd (IBD)
Wisdomtree Tr Floatng Rat Trea (USFR)
Caterpillar (CAT)
Servicenow (NOW)
Northern Lts Fd Tr Iv Inspire Intl Etf (WWJD)
Northern Lts Fd Tr Iv Inspire Gbl Hope (BLES)
Prologis (PLD)
Intuitive Surgical Com New (ISRG)
Stryker Corporation (SYK)
Northern Lts Fd Tr Iv Inspire Sml/ Mid (ISMD)
Progressive Corporation (PGR)
Synopsys (SNPS)
Arista Networks (ANET)
Amphenol Corp Cl A (APH)
Kla Corp Com New (KLAC)

View all positions for CWM Advisors

Top funds holding Protagonist Therapeutics

BVF
Vanguard Group
Point72 Asset Management
Kynam Capital Management
Cowen And Company
Deutsche Bank Aktiengesellschaft
T. Rowe Price Associates
Dimensional Fund Advisors
683 Capital Management
Candriam Luxembourg S.C.A.
Goldman Sachs Group
Charles Schwab Investment Management
Citadel Advisors
Jpmorgan Chase & Co
Gratus Capital

View all funds holding Protagonist Therapeutics